Literature DB >> 34339684

Optimal NIV Medicare Access Promotion: Patients With COPD: A Technical Expert Panel Report From the American College of Chest Physicians, the American Association for Respiratory Care, the American Academy of Sleep Medicine, and the American Thoracic Society.

Nicholas S Hill1, Gerard J Criner2, Richard D Branson3, Bartolome R Celli4, Neil R MacIntyre5, Amen Sergew6.   

Abstract

This document summarizes the work of the COPD Technical Expert Panel working group. For patients with COPD, the most pressing current coverage barriers identified were onerous diagnostic requirements focused on oxygenation (rather than ventilation) and difficulty obtaining bilevel devices with backup rate capabilities. Because of these difficulties, many patients with COPD were instead sometimes prescribed home mechanical ventilators. Critical evidence supports changes to current policies, including randomized controlled trial evidence suggesting a mortality benefit from bilevel positive airway pressure with backup rate and updated clinical practice guidelines from the American Thoracic Society as well as the European Respiratory Society. To achieve optimal access to noninvasive ventilation for patients with COPD, we make the following key recommendations: (1) removal of the need for overnight oximetry testing; (2) the ability to initiate therapy using bilevel devices with backup rate capability; and (3) increased duration of time to meet adherence criteria (ie, a second 90-day trial period) in those patients actively engaged in their care. Clear guidelines based on medical necessity are also included for patients who require initiation of or switch to a home mechanical ventilator. Adoption of these proposed recommendations would result in the right device, for the right type of patient with COPD, at the right time. Finally, we emphasize the need for adequate clinical support during initiation and maintenance of home noninvasive ventilation in such patients.
Copyright © 2021 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  COPD; hypercapnic respiratory failure; mechanical ventilation; noninvasive ventilation

Mesh:

Year:  2021        PMID: 34339684      PMCID: PMC8628175          DOI: 10.1016/j.chest.2021.06.082

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  21 in total

Review 1.  Nocturnal monitoring of home non-invasive ventilation: the contribution of simple tools such as pulse oximetry, capnography, built-in ventilator software and autonomic markers of sleep fragmentation.

Authors:  Jean-Paul Janssens; Jean-Christian Borel; Jean-Louis Pépin
Journal:  Thorax       Date:  2010-10-22       Impact factor: 9.139

2.  Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial.

Authors:  Thomas Köhnlein; Wolfram Windisch; Dieter Köhler; Anna Drabik; Jens Geiseler; Sylvia Hartl; Ortrud Karg; Gerhard Laier-Groeneveld; Stefano Nava; Bernd Schönhofer; Bernd Schucher; Karl Wegscheider; Carl P Criée; Tobias Welte
Journal:  Lancet Respir Med       Date:  2014-07-24       Impact factor: 30.700

3.  Efficacy and compliance with noninvasive positive pressure ventilation in patients with chronic respiratory failure.

Authors:  G J Criner; K Brennan; J M Travaline; D Kreimer
Journal:  Chest       Date:  1999-09       Impact factor: 9.410

4.  Nocturnal non-invasive ventilation in COPD patients with prolonged hypercapnia after ventilatory support for acute respiratory failure: a randomised, controlled, parallel-group study.

Authors:  F M Struik; R T M Sprooten; H A M Kerstjens; G Bladder; M Zijnen; J Asin; N A M Cobben; J M Vonk; P J Wijkstra
Journal:  Thorax       Date:  2014-04-29       Impact factor: 9.139

5.  Long-Term Noninvasive Ventilation in the Geneva Lake Area: Indications, Prevalence, and Modalities.

Authors:  Chloé Cantero; Dan Adler; Patrick Pasquina; Christophe Uldry; Bernard Egger; Maura Prella; Alain B Younossian; Paola M Soccal; Jean-Louis Pépin; Jean-Paul Janssens
Journal:  Chest       Date:  2020-03-31       Impact factor: 9.410

Review 6.  Nocturnal non-invasive positive pressure ventilation for stable chronic obstructive pulmonary disease.

Authors:  Fransien M Struik; Yves Lacasse; Roger Goldstein; Huib M Kerstjens; Peter J Wijkstra
Journal:  Cochrane Database Syst Rev       Date:  2013-06-13

7.  Long-term adherence with non-invasive ventilation improves prognosis in obese COPD patients.

Authors:  Jean-Christian Borel; Jean-Louis Pepin; Christophe Pison; Aurélien Vesin; Jesus Gonzalez-Bermejo; Isabelle Court-Fortune; Jean-François Timsit
Journal:  Respirology       Date:  2014-06-09       Impact factor: 6.424

8.  Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group.

Authors: 
Journal:  Ann Intern Med       Date:  1980-09       Impact factor: 25.391

9.  Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.

Authors:  Claus F Vogelmeier; Gerard J Criner; Fernando J Martinez; Antonio Anzueto; Peter J Barnes; Jean Bourbeau; Bartolome R Celli; Rongchang Chen; Marc Decramer; Leonardo M Fabbri; Peter Frith; David M G Halpin; M Victorina López Varela; Masaharu Nishimura; Nicolas Roche; Roberto Rodriguez-Roisin; Don D Sin; Dave Singh; Robert Stockley; Jørgen Vestbo; Jadwiga A Wedzicha; Alvar Agustí
Journal:  Am J Respir Crit Care Med       Date:  2017-03-01       Impact factor: 21.405

10.  Long-Term Noninvasive Ventilation in Chronic Stable Hypercapnic Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline.

Authors:  Madalina Macrea; Simon Oczkowski; Bram Rochwerg; Richard D Branson; Bartolome Celli; John M Coleman; Dean R Hess; Shandra Lee Knight; Jill A Ohar; Jeremy E Orr; Amanda J Piper; Naresh M Punjabi; Shilpa Rahangdale; Peter J Wijkstra; Susie Yim-Yeh; M Bradley Drummond; Robert L Owens
Journal:  Am J Respir Crit Care Med       Date:  2020-08-15       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.